351 related articles for article (PubMed ID: 14555981)
1. Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.
Boerner JL; Danielsen AJ; Lovejoy CA; Wang Z; Juneja SC; Faupel-Badger JM; Darce JR; Maihle NJ
Oncogene; 2003 Oct; 22(43):6679-89. PubMed ID: 14555981
[TBL] [Abstract][Full Text] [Related]
2. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
Danielsen AJ; Maihle NJ
Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
[TBL] [Abstract][Full Text] [Related]
3. An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex.
McManus MJ; Boerner JL; Danielsen AJ; Wang Z; Matsumura F; Maihle NJ
J Biol Chem; 2000 Nov; 275(45):35328-34. PubMed ID: 10954714
[TBL] [Abstract][Full Text] [Related]
4. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2.
Charest A; Wagner J; Kwan M; Tremblay ML
Oncogene; 1997 Apr; 14(14):1643-51. PubMed ID: 9135065
[TBL] [Abstract][Full Text] [Related]
5. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
6. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.
Rozakis-Adcock M; Fernley R; Wade J; Pawson T; Bowtell D
Nature; 1993 May; 363(6424):83-5. PubMed ID: 8479540
[TBL] [Abstract][Full Text] [Related]
7. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases.
Miki H; Miura K; Takenawa T
EMBO J; 1996 Oct; 15(19):5326-35. PubMed ID: 8895577
[TBL] [Abstract][Full Text] [Related]
8. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of growth factor receptor binding protein-2 by pp60c-src tyrosine kinase.
Jones DA; Benjamin CW
Arch Biochem Biophys; 1997 Jan; 337(2):143-8. PubMed ID: 9016807
[TBL] [Abstract][Full Text] [Related]
10. Membrane localization of v-ErbB is required but not sufficient for ligand-independent transformation.
Danielsen AJ; Christensen TA; Lovejoy CA; Adelsman MA; Connolly DC; Maihle NJ
Exp Cell Res; 2004 Jun; 296(2):285-93. PubMed ID: 15149858
[TBL] [Abstract][Full Text] [Related]
11. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
12. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling.
Li N; Batzer A; Daly R; Yajnik V; Skolnik E; Chardin P; Bar-Sagi D; Margolis B; Schlessinger J
Nature; 1993 May; 363(6424):85-8. PubMed ID: 8479541
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
Li S; Couvillon AD; Brasher BB; Van Etten RA
EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
[TBL] [Abstract][Full Text] [Related]
14. A Grb2-associated docking protein in EGF- and insulin-receptor signalling.
Holgado-Madruga M; Emlet DR; Moscatello DK; Godwin AK; Wong AJ
Nature; 1996 Feb; 379(6565):560-4. PubMed ID: 8596638
[TBL] [Abstract][Full Text] [Related]
15. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M
Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
17. A transformation-associated complex involving tyrosine kinase signal adapter proteins and caldesmon links v-erbB signaling to actin stress fiber disassembly.
McManus MJ; Lingle WL; Salisbury JL; Maihle NJ
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11351-6. PubMed ID: 9326613
[TBL] [Abstract][Full Text] [Related]
18. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
Zhou D; Chen B; Ye JJ; Chen S
Oncogene; 2004 Jul; 23(31):5394-404. PubMed ID: 15122321
[TBL] [Abstract][Full Text] [Related]
19. Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis.
Bardelli A; Basile ML; Audero E; Giordano S; Wennström S; Ménard S; Comoglio PM; Ponzetto C
Oncogene; 1999 Feb; 18(5):1139-46. PubMed ID: 10022119
[TBL] [Abstract][Full Text] [Related]
20. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
